Technology for Paralysis Outpaces Funding
Among the biggest challenges in medical technology is the search for therapies to help patients regain body function after suffering a paralyzing spinal cord injury. Research in this area is producing some very promising theories and applications that eventually could lead to substantial breakthroughs. Teams of doctors and scientists continue to work diligently in what can be described as a dedicated, niche market, where the driving force is tied to the very basic medical goal of improving these patients' quality of life.
You may also be interested in...
Based on promising Phase II data, two companies in South Korea are moving ahead with late-stage development in the gout space, with JW Pharmaceutical getting approvals to begin a multinational Phase III program for epaminurad, while LG Chem has recently submitting an application for a new Phase III trial with its contender tigulixostat.
Final guidance targets the ‘multiplicity problem.’ At about half the length of the 2017 draft, the final removes some sections, truncates other and drops several examples.
US Health and Human Services Department revises approach to 340B administrative dispute resolution process and presiding panel in proposed rule.